Circulating neuregulin-1 levels in polycystic ovary syndrome

References

• Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. 2009. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility 91: 456–488.
   PubMed Web of Science ®Google Scholar
• Britsch S. 2007. The neuregulin-I/ErbB signaling system in development and disease (Vol. 190). Advances in Anatomy, Embryology, and Cell Biology 190:1.
   PubMed Web of Science ®Google Scholar
• Carmina E, Rosato F, Janni A, Rizzo M, Longo RA. 2006. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. The Journal of Clinical Endocrinology and Metabolism 91:2–6.
   PubMed Web of Science ®Google Scholar
• Carraway KL, III, Cantley LC. 1994. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78:5–8.
   PubMed Web of Science ®Google Scholar
• Carver RS, Mathew PM, Russell WE. 1997. Hepatic expression of ErbB3 is repressed by insulin in a pathway sensitive to PI-3 kinase inhibitors. Endocrinology 138:5195–5201.
   PubMed Web of Science ®Google Scholar
• Carver RS, Sliwkowski MX, Sitaric S, Russell WE. 1996. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes. The Journal of Biological Chemistry 271:13491–13496.
   PubMed Web of Science ®Google Scholar
• Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. 2016. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Human Reproduction (Oxford, England) 31:2619–2631.
   PubMed Web of Science ®Google Scholar
• Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, et al. 2015. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nature Communications 6:8464.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. 2012. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews 33: 981–1030.
   PubMed Web of Science ®Google Scholar
• Dimayuga FO, Ding Q, Keller JN, Marchionni MA, Seroogy KB, Bruce-Keller AJ. 2003. The neuregulin GGF2 attenuates free radical release from activated microglial cells. Journal of Neuroimmunology 136: 67–74.
   PubMed Web of Science ®Google Scholar
• Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, et al. 2003. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 88: 3626–3631.
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Akopians AL, Madrigal VK, Ramirez E, Margolis DJ, Sarma MK, et al. 2016. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. The Journal of Clinical Endocrinology and Metabolism 101: 4178–4188.
   PubMed Web of Science ®Google Scholar
• Dunaif A. 1997. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18: 774–800.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Roldán-Martín MB. 2016. Type 1 diabetes and polycystic ovary syndrome: systematic review and meta-analysis. Diabetes Care 39:639–648.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. 2012. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 97:28–38.
   PubMed Web of Science ®Google Scholar
• Fenichel P, Rougier C, Hieronimus S, Chevalier N. 2017. Which origin for polycystic ovaries syndrome: Genetic, environmental or both? Annales D'Endocrinologie 78:176–185.
   PubMed Web of Science ®Google Scholar
• Ferriman D, Gallwey JD. 1961. Clinical assessment of body hair growth in women. The Journal of Clinical Endocrinology and Metabolism 21:1440–1447.
   PubMed Web of Science ®Google Scholar
• Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E. 2015. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1. Endocrine Practice 21:1291–1300.
   PubMed Web of Science ®Google Scholar
• Gui C, Zhu L, Hu M, Lei L, Long Q. 2012. Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy. Cardiovascular Pathology : The Official Journal of the Society for Cardiovascular Pathology 21:414–420.
   PubMed Web of Science ®Google Scholar
• Jie B, Zhang X, Wu X, Xin Y, Liu Y, Guo Y. 2012. Neuregulin-1 suppresses cardiomyocyte apoptosis by activating PI3K/Akt and inhibiting mitochondrial permeability transition pore. Molecular and Cellular Biochemistry 370:35–43.
   PubMed Web of Science ®Google Scholar
• Kawashima I, Umehara T, Noma N, Kawai T, Shitanaka M, Richards JS, et al. 2014. Targeted disruption of Nrg1 in granulosa cells alters the temporal progression of oocyte maturation. Molecular Endocrinology 28:706–721.
   PubMedGoogle Scholar
• Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N, et al. 2001. Low grade chronic inflammation in women with polycystic ovarian syndrome. The Journal of Clinical Endocrinology and Metabolism 86:2453–2455.
   PubMed Web of Science ®Google Scholar
• Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. 2013. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 98:4565–4592.
   PubMed Web of Science ®Google Scholar
• Livadas S, Kollias A, Panidis D, Diamanti-Kandarakis E. 2014. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome. European Journal of Endocrinology 171:301–309.
   PubMed Web of Science ®Google Scholar
• Macut D, Bjekić-Macut J, Rahelić D, Doknić M. 2017. Insulin and the polycystic ovary syndrome. Diabetes Research and Clinical Practice 130:163–170.
   PubMed Web of Science ®Google Scholar
• Mani H, Levy MJ, Davies MJ, Morris DH, Gray LJ, Bankart J, et al. 2013. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clinical Endocrinology 78:926–934.
   PubMed Web of Science ®Google Scholar
• Mao J, Whitworth KM, Spate LD, Walters EM, Zhao J, Prather RS. 2012. Regulation of oocyte mitochondrial DNA copy number by follicular fluid, EGF, and neuregulin 1 during in vitro maturation affects embryo development in pigs. Theriogenology 78: 887–897.
   PubMed Web of Science ®Google Scholar
• Marballi K, Quinones MP, Jimenez F, Escamilla MA, Raventós H, Soto-Bernardini MC, et al. 2010. In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulation. Journal of Molecular Medicine (Berlin, Germany) 88:1133–1141.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 2:412–419.
   PubMed Web of Science ®Google Scholar
• Meyer D, Yamaai T, Garratt A, Riethmacher-Sonnenberg E, Kane D, Theill LE, et al. 1997. Isoform-specific expression and function of neuregulin. Development 124:3575–3586.
   PubMed Web of Science ®Google Scholar
• Moran LJ, Misso ML, Wild RA, Norman RJ, 2010. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 1:347–363.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, et al. 1991. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism 7, 83–89.
   PubMed Web of Science ®Google Scholar
• Noma N, Kawashima I, Fan HY, Fujita Y, Kawai T, Tomoda Y, et al. 2011. LH-induced neuregulin 1 (NRG1) type III transcripts control granulosa cell differentiation and oocyte maturation. Molecular Endocrinology 25:104–116.
   PubMedGoogle Scholar
• Odiete O, Konik EA, Sawyer DB, Hill MF. 2013. Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure. Cardiovascular Diabetology 12:52.
   PubMed Web of Science ®Google Scholar
• Pan P, Dobrowsky RT. 2013. Differential expression of neuregulin-1 isoforms and downregulation of erbin are associated with Erb B2 receptor activation in diabetic peripheral neuropathy. Acta Neuropathologica Communications 1:39.
   PubMed Web of Science ®Google Scholar
• Peng Y, Zhang W, Yang P, Tian Y, Su S, Zhang C, et al. 2017. ERBB4 confers risk for polycystic ovary syndrome in Han Chinese. Scientific Reports 7:42000.
   PubMed Web of Science ®Google Scholar
• Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ. 1992. Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene 7:1273–1278.
   PubMed Web of Science ®Google Scholar
• Richani D, Gilchrist RB. 2017. The epidermal growth factor network: role in oocyte growth, maturation and developmental competence. Human Reproduction Update 24:1–14.
   Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM‐sponsored PCOS consensus workshop group. 2004. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19:41–47.
   PubMed Web of Science ®Google Scholar
• Ruvolo G, Fattouh RR, Bosco L, Brucculeri AM, Cittadini E. 2013. New molecular markers for the evaluation of gamete quality. Journal of Assisted Reproduction and Genetics 30:207–212.
   PubMed Web of Science ®Google Scholar
• Shimada M, Umehara T, Hoshino Y. 2016. Roles of epidermal growth factor (EGF)-like factor in the ovulation process . Reproductive Medicine and Biology 15:201–216.
   PubMedGoogle Scholar
• Shorakae S, Teede H, de Courten B, Lambert G, Boyle J, Moran LJ. 2015. The emerging role of chronic low-grade inflammation in the pathophysiology of polycystic ovary syndrome. Seminars in Reproductive Medicine 33:257–269. Thieme Medical Publishers.
   PubMed Web of Science ®Google Scholar
• Srinivasan R, Poulsom R, Hurst HC, Gullick WJ. 1998. Expression of the c‐erbB‐4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. The Journal of Pathology 185:236–245.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Deeks AA, Moran LJ, Stuckey BG, Wong JL, et al. 2011. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. The Medical Journal of Australia 195:S65.
   PubMed Web of Science ®Google Scholar
• Timolati F, Ott D, Pentassuglia L, Giraud MN, Perriard JC, Suter TM, et al. 2006. Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. Journal of Molecular and Cellular Cardiology 41:845–854.
   PubMed Web of Science ®Google Scholar
• Vigil P, Contreras P, Alvarado JL, Godoy A, Salgado AM, Cortés ME. 2007. Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Human Reproduction (Oxford, England) 22:2974–2980.
   PubMed Web of Science ®Google Scholar